Navigation Links
Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
Date:11/29/2007

ATLANTA, Nov. 29 /PRNewswire-USNewswire/ -- Recent research from the Barbara Ann Karmanos Cancer Institute in Detroit, MI, suggests black cancer patients are less likely than white cancer patients to bring a companion with them to physician appointments, leading to possible racial disparities in informed decision-making about cancer treatment and participation in clinical trials.

This research further examines cancer patient question-asking and the role of companions during physician visits. In the past, it has been shown that patients who bring a companion with them to physician visits receive more information than those who don't.

Susan Eggly, Ph.D., assistant professor of internal medicine and member of the Communication and Behavioral Oncology program at Karmanos, presented the findings at the American Association for Cancer Research's The Science of Cancer Health Disparities conference this week in Atlanta, GA.

Nationally, clinical trials accrue disproportionately low rates of minority patients. Dr. Eggly and researchers at Karmanos believe the low rate of accrual may partially be influenced by physician-patient communication during the clinical interactions in which trials are offered.

The study showed that black and white patients both asked more questions during visits to the doctor that included an offer of a clinical trial than visits that included only standard treatment options. However, in both types of visits, black patients asked fewer questions and less frequently had a companion present to assist them in asking questions. Because increased questioning has been associated with positive patient outcomes, these findings may reveal some causes of racial health disparities, especially with regard to how much information patients get about treatment and other options for care.

"Our program is particularly interested in the way patients and companions ask questions because question-asking is associated wi
'/>"/>

SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
2. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
3. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
4. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
5. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
6. U. of Md. Researchers to Develop Devices to Revolutionize Drug Research
7. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
8. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
9. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
10. Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
11. Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "12th Annual Report ... report to their offering. The ... Manufacturing Capacity and Production is the most recent ... current and projected future capacity and production. The ...
(Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Quetiapine Market, ... Developed by AstraZeneca plc, quetiapine (under the trade ... the treatment of schizophrenia. Approved by CFDA to ... the Catalogue of Drugs for the Basic National ...
(Date:8/28/2015)... The scientific team of a new ... the leading academics in the field of aging Prof. ... life extension for model animals - 10 fold for nematodes) ... age-related diseases, primarily, around the stability and stress resistance of ... as "Stability analysis of a model gene network links aging, ...
Breaking Medicine Technology:12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Quetiapine Market Investigation Report 2010-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
... Philips recently recalled specific lots of infant ... H Set Microstream carbon dioxide (CO2) sampling lines ... Lot CodesM1923A , Philips Filterline H Set ... Set Infant/Neo , M8409P10Philips initiated the recall in ...
... Technologies Corp. (NASDAQ: BSTC ), a ... today provided an update on the launch progress ... reported by BioSpecifics, strategic partner, Auxilium Pharmaceuticals, Inc. ... Pfizer, Inc. (Pfizer) in 7 European countries: the ...
Cached Medicine Technology:Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines 2BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU 2BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU 3
(Date:8/28/2015)... ... 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients ... pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. ... and then went on to earn his title of Doctor of Chiropractic from the ...
(Date:8/28/2015)... ... 2015 , ... Mendon, IL, home of the Adams County Fairgrounds, was treated ... a good cause. In its second year, the “Music With A Mission” benefit concert ... The “Mission” of “Music With A Mission” is to raise money to help fund ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... The newest ... not be available for general use any time soon, according to educational website Surviving ... biologic therapy that received orphan drug designation for mesothelioma last week from the FDA, ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... External Counterpulsation, ... Heart Fit Clinic is now selling External Counterpulsation (EECP or ECP) machines with a ... Fit Clinic has been in business since 2007 helping people prevent and reverse ...
(Date:8/28/2015)... ... August 28, 2015 , ... Inc. magazine today ranked ... an exclusive ranking of the nation’s fastest-growing private companies. The list was unveiled online ... growth of 85% over the last three years, PREVENT ranks higher on the list ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2
... gloss, depth of image, and surface ... Texas, Oct. 22 Solvay Engineered Polymers,Inc., has ... in the,production of extruded sheet. The new ADDHERE(TM) ... layer onto a substrate of thermoplastic,polyolefin (TPO) for ...
... with Top Children,s Miracle Network Health Experts, SALT LAKE CITY, Oct. 22 /PRNewswire/, ... experts from 170 Children,s ... questions about Methicillin-resistant Staphylococcus Aureus ... to antibiotics, and other ...
... Chairman Howard Dean issued the following statement in response,to ... $46 billion,in war spending, for a total of $196 ... coverage to 10 million of America,s low income children:, ... to fund his war of,choice in Iraq but has ...
... There,s no proof cancer will spread to the ... (HealthDay News) -- Women diagnosed with breast cancer who ... other, healthy breast removed as a preventive measure. , ... mastectomy, more than doubled from 1998 to 2003, according ...
... 22 The start of the,patent lawsuit by VNUS(R) ... laser competitors, Diomed, AngioDynamics and Vascular,Solutions, has been delayed ... delay is due to a busy court calendar. A ... new trial start dates. At,the conference, the parties will ...
... 22 Dialysis Corporation,of America (Nasdaq: DCAI ... third,quarter 2007 earnings after the close of the ... of America owns and operates freestanding kidney,hemodialysis centers ... Carolina and Virginia, and provides in-hospital,dialysis services on ...
Cached Medicine News:Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2
Coated-Tube (CT) RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum...
RIA kit for the quantitative determination of autoantibodies to thyroglobulin in serum....
For the quantitative determination of Estradiol (E2) concentration in human serum or plasma....
... Estradiol (E2) is the most potent, naturally ... produced by the ovary [1]. In the ... and from estrone, a less potent estrogen ... interconverted in many body tissues. In men, ...
Medicine Products: